web analytics
12.6 C
Munich
Sunday, May 29, 2022

What Do You Know about Biotech Products Services & Research Inc (OTCMKTS:BPSR)

Biotech Products Services & Research Inc (OTCMKTS:BPSR) started trading at the $0.50 cent mark in early February and has been rising steadily since then on fast accelerating volume quickly establishing itself as a volume leader on the OTC.

BPSR is a major league stock promotion with a disclosed budget of $575,000 and a landing page at financialnews.com and a video here that is reminiscent of Mike Statler from now defunct StockTips.

Biotech Products Services & Research Inc (OTCMKTS:BPSR) bills itself as a lifestyle, health and wellness Company with a vision of becoming vertically integrated, which primarily provides a patient referral service for integrative cellular therapies. Biotech also markets cellular products to doctors and hospitals.

Biotech aims to be the leader in the industry of innovative cell-based therapeutic with our unique strategy which will guide a future of customized disease management. Biotech also sells women’s fashion products through its Ethan New York subsidiary as part of our vertically integrated health and wellness vision.

BPSR was incorporated as Bespoke Tricycles Inc. on August 8, 2011 in the State of Nevada for the purpose of designing, manufacturing, and selling vending tricycles for commercial customers. On August 10, 2011, the Company purchased all of the issued and outstanding shares of Bespoke Tricycles, Ltd. from current officer and director, John Goodhew, in exchange for 5,000,000 shares of our common stock.

According to the disclaimer ”For current services performed WSG has been compensated five hundred and seventy-five thousand U.S. dollars ($575,000.00 US) for 4 weeks coverage of BPSR by a non-affiliated third party.”

To Find out the inside Scoop on BPSR Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

On January 22 BPSR announced the launch of its wholly-owned subsidiary, General Surgical Florida, Inc. The team at General Surgical will work towards establishing sales distribution channels of regenerative products to hospitals, physicians and third party distributors. Specifically, General Surgical will be providing access to advanced regenerative medical technologies and expanding education services to providers in the Company’s referral network.

BPSR CEO Albert Mitrani said “This new branch of Biotech, we believe, will increase the depth of the patient referral network in our associated Beyond Cells subsidiary, as well as set the stage for sales and distribution of future product lines. We look forward to providing further information about General Surgical as developments occur.”

The landing page on BPSR starts with ”Could this be the Hottest Biotech in 2016? A new biotech company is starting to gain investor interest in trading circles and social media alike. Until recently this little biotech has not been on anyone’s radar, and just recently this has started to change.

It continues ‘’ BPSR has a subsidiary called Beyond Cells which is a referral service for patients looking for stem cell therapies. Beyond Cells determines the patient’s needs and points them in the direction of a doctor or clinic that can help them. Beyond Cells is already up and running, generating cash and looking to expand.

BPSR has another subsidiary called BD Source which plans to develop, patent and sell its own stem cell therapies and in the meantime has just signed an agreement with a supplier to supply BD Source with products to sell to the medical establishment.

Currently trading at a $101 million market valuation BPSR has minimal assets or revenues and rising short term debt. The stock is a multi-million dollar promotion that could easily move much higher short term. The stock currently being liquidated into the campaign are likely the 840,000 shares sold to private investors 2 years ago at $0.05 each. After the 18-for-1 forward split in September 2015 those same shares are now 15.1 million free trading BPSR. Short term BPSR could easily move much higher as long as the promo dollars continue to flow, long term the stock lacks the fundamentals to support anywhere near current market valuations and could drop big. We will be updating on BPSR as events unfold so make sure you are subscribed to Microcapdaily so you know what is going on with BPSR.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in BPSR either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.